Carter, M J
Cox, K L
Blakemore, S J
Bogdanov, Y D
Happo, L
Scott, C L
Strasser, A
Packham, G K
Cragg, M S
Article History
Received: 3 December 2014
Revised: 17 May 2015
Accepted: 11 June 2015
First Online: 17 July 2015
Competing interests
: MSC acts as a consultant to Bioinvent International and has received grant funding from them. He has previously served as anad hocconsultant for Roche and has also received grant funding from Roche-Glycart. AS acts as a consultant for Genentech. The remaining authors declare no conflict of interest.